Latest Capital Deployment News

Stonehorse Energy’s first well in Alberta’s Ellerslie reservoir is producing ahead of schedule and below budget, prompting plans for three more wells in 2026 to deepen its foothold in Western Canada.

Felix Gold Limited has successfully raised $18 million through a placement to fund exploration and advance near-term military-grade antimony production in Alaska. The capital injection positions the company to capitalize on strategic supply opportunities amid global market shifts.

APA Group’s BBB credit rating is affirmed by S&P with a key modification that expands its borrowing power by over $1 billion, positioning the energy infrastructure giant for accelerated growth.

E79 Gold Mines has completed its acquisition of Cue Metals, gaining control of the Cue Gold Project in Western Australia, while appointing mining veteran Matthew Bowles to its board. The company is set to launch an intensive exploration program starting this December.

APC Minerals Limited has initiated a fully underwritten pro-rata renounceable entitlement offer to raise approximately $1.38 million at $0.004 per share, aiming to fund its exploration projects and working capital needs.

Maggie Beer Holdings Ltd has announced a 1-for-10 non-renounceable entitlement offer priced at $0.056 per share, aiming to raise approximately $2.28 million to bolster its balance sheet and working capital. Eligible shareholders in Australia and New Zealand can participate, with options to apply for additional shares and a potential shortfall placement.

Veris Limited has completed the acquisition of Melbourne-based Mesh and a 50% stake in the Parsel digital platform, marking a strategic push into higher-margin digital advisory services.

PeopleIN Limited is set to divest its majority stake in Techforce Personnel, securing over a 100% return and strengthening its balance sheet to fuel future acquisitions.

Redivium Limited has postponed the completion of its UK lithium-ion battery recycling feasibility study to Q2 2026 due to a site relocation requiring updated environmental assessments. Meanwhile, its European projects in Czechia and Romania continue to advance steadily.

Mesoblast has achieved a landmark FDA approval for RYONCIL, the first allogeneic mesenchymal stromal cell therapy, driving strong commercial momentum and advancing a robust pipeline targeting inflammatory diseases.

Viridis Mining and Minerals has locked in a US$30 million strategic funding agreement with Brazilian asset managers Régia Capital and ORE Investments, setting a clear path to Final Investment Decision for its Colossus rare earth project.

Sietel Limited’s preliminary final report for FY2025 reveals a 47% drop in net profit and a 24% fall in total revenues, underscoring a challenging year for the investment management firm.